Real-world comparison of bleeding risks among non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, or rivaroxaban-Reference-Cited by-同舟云学术

Real-world comparison of bleeding risks among non-valvular atrial fibrillation patients prescribed apixaban, dabigatran, or rivaroxaban

Published:2018-11-01 Issue:11 Volume:13 Page:e0205989
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Tepper Ping G.^ORCID,Mardekian Jack,Masseria Cristina,Phatak Hemant,Kamble Shital,Abdulsattar Younos,Petkun William,Lip Gregory Y. H.

Funder

Bristol-Myers Squibb

Pfizer

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference33 articles.

1. Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study;C Marini;Stroke,2005

2. Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop;EJ Benjamin;Circulation,2009

3. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation;RG Hart;Ann Intern Med,2007

4. Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation;P Gallego;Thromb Haemost,2013

5. Vitamin K antagonists in heart disease: current status and perspectives (Section III): position paper of the ESC Working Group on Thrombosis—task force on anticoagulants in heart disease;R De Caterina;Thromb Haemost,2013

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can edoxaban be used at extremes of bodyweight and in patients with a creatinine clearance ≥95 ml/min? – A population pharmacokinetic analysis;Thrombosis Research;2024-10

2. Echocardiographic Hemodynamics Correlate with Differences in DOAC-specific Bleeding and Stroke Rates in Non-Valvular Atrial Fibrillation;2024-08-26

3. In vitro effects of Gla-domainless factor Xa analog on procoagulant and fibrinolytic pathways in apixaban-treated plasma and whole blood;Thrombosis Research;2023-10

4. Healthcare resources and costs associated with nonvalvular atrial fibrillation in Spain: apixaban versus acenocoumarol;Journal of Comparative Effectiveness Research;2023-08

5. Evaluation of the Inappropriate Prescribing Practices of Rivaroxaban and Their Association with Bleeding in Tertiary Care Hospitals in Saudi Arabia;Saudi Journal of Clinical Pharmacy;2023-04